These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26087105)

  • 41. SDRIFE (baboon syndrome) due to paracetamol: case report.
    Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
    Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of symmetrical drug-related intertriginous and flexural exanthema induced by acetaminophen.
    Obara K; Maejima H; Katayama C; Takasu H; Amoh Y
    J Dermatol; 2014 Dec; 41(12):1132-3. PubMed ID: 25385002
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.
    Kardaun SH; de Monchy JG
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S21-3. PubMed ID: 16843118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) with fever induced by oral cloxacillin: does fever confound the diagnosis?
    Chong WS; Lim HL
    J Dermatol; 2010 Sep; 37(9):830-2. PubMed ID: 20883371
    [No Abstract]   [Full Text] [Related]  

  • 45. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema.
    Kim EY; Awh KC; Larocca CA
    Acta Derm Venereol; 2023 Dec; 103():adv12197. PubMed ID: 38112207
    [No Abstract]   [Full Text] [Related]  

  • 46. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
    Kalita BJ; Das S; Dutta B
    Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
    [No Abstract]   [Full Text] [Related]  

  • 47. Symmetrical drug-related intertriginous and flexural exanthema caused by celecoxib.
    Kim BJ; Kim HS; Lee JY; Kim HO; Park YM; La HO
    Int J Dermatol; 2014 Jan; 53(1):e1-3. PubMed ID: 22591259
    [No Abstract]   [Full Text] [Related]  

  • 48. Amoxycillin-induced flexural exanthem.
    Wakelin SH; Sidhu S; Orton DI; Chia Y; Shaw S
    Clin Exp Dermatol; 1999 Mar; 24(2):71-3. PubMed ID: 10233656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rare case of symmetrical drug-related intertriginous and flexural exanthema due to pantoprazole.
    Kothari R; Pal R; Bhatnagar A; Kishore K; Patil C
    Int J Dermatol; 2022 Sep; 61(9):e330-e331. PubMed ID: 35235207
    [No Abstract]   [Full Text] [Related]  

  • 50. Symmetrical Intertriginous and Flexural Exanthema due to Bortezomib (a Proteasome Inhibitor) Given for Myeloma.
    Malissen N; Bourrain JL; Chiriac A; Montet A; Vincent L; Dereure O; Du-Thanh A
    Acta Derm Venereol; 2016 Nov; 96(7):995-996. PubMed ID: 27001285
    [No Abstract]   [Full Text] [Related]  

  • 51. Intertriginous eruption induced by terbinafine: a review of baboon syndrome.
    Janjua SA; Pastar Z; Iftikhar N; Ammad S
    Int J Dermatol; 2017 Jan; 56(1):100-103. PubMed ID: 27153516
    [No Abstract]   [Full Text] [Related]  

  • 52. Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression.
    Cavicchini S; Vezzoli P; Muratori S; Gianotti R
    Clin Exp Dermatol; 2009 Jun; 34(4):526-7. PubMed ID: 19196306
    [No Abstract]   [Full Text] [Related]  

  • 53. Symmetrical drug-related intertriginous and flexural exanthema induced by two different antibiotics.
    Can C; Yazicioglu M; Ozdemir PG; Kilavuz S; Tastekin E
    Allergol Immunopathol (Madr); 2014; 42(2):173-5. PubMed ID: 23253684
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of symmetrical drug-related intertriginous and flexural exanthema induced by loflazepate ethyl.
    Watanabe T; Yamada N; Yoshida Y; Yamamoto O
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):357-8. PubMed ID: 19732255
    [No Abstract]   [Full Text] [Related]  

  • 55. Symmetrical drug-related intertriginous and flexural exanthema-like rash related to severe acute respiratory syndrome coronavirus 2 infection.
    Escolà H; March-Rodriguez A; Pujol RM
    Indian J Dermatol Venereol Leprol; 2023; 89(1):119-121. PubMed ID: 36331827
    [No Abstract]   [Full Text] [Related]  

  • 56. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
    Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
    Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
    [No Abstract]   [Full Text] [Related]  

  • 57. Tacrolimus-induced symmetric drug-related intertriginous and flexural exanthema (SDRIFE).
    Scherrer M; Araujo MG; Farah K
    Contact Dermatitis; 2018 Jun; 78(6):414-416. PubMed ID: 29722025
    [No Abstract]   [Full Text] [Related]  

  • 58. Varenicline-induced symmetrical drug-related intertriginous and flexural exanthema.
    Cheng CY; Wang CW; Wang FY; Chung WH
    Indian J Dermatol Venereol Leprol; 2019; 85(2):209-211. PubMed ID: 30719986
    [No Abstract]   [Full Text] [Related]  

  • 59. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
    Camela E; Scalvenzi M; Megna M; Potestio L; Guerrasio G; Fornaro L; Fabbrocini G; Costa C
    Dermatol Ther; 2022 Dec; 35(12):e15881. PubMed ID: 36181410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.